Teladoc Health Inc
TDOC7.485USD
-0.035-0.47%
Handelsschluss 08/18, 16:00（ET）Kurse um 15 Minuten verzögert
1.32BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Teladoc Health Inc Unternehmen
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
Unternehmensinformationen
BörsenkürzelTDOC
Name des UnternehmensTeladoc Health Inc
IPO-datumJul 01, 2015
CEOMr. Charles (Chuck) Divita, III
Anzahl der mitarbeiter5500
WertpapierartOrdinary Share
GeschäftsjahresendeJul 01
Addresse155 E 44Th Street
StadtNEW YORK
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl10017
Telefon12036352002
Websitehttps://www.teladochealth.com/
BörsenkürzelTDOC
IPO-datumJul 01, 2015
CEOMr. Charles (Chuck) Divita, III
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
156.64K
--
Ms. Mala Murthy
Ms. Mala Murthy
Chief Financial Officer
Chief Financial Officer
132.44K
-9.47%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
69.77K
-7.68%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
50.27K
-8.47%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+117.92%
Dr. Mark Douglas Smith, M.D.
Dr. Mark Douglas Smith, M.D.
Independent Director
Independent Director
8.36K
--
Mr. David B. Snow, Jr.
Mr. David B. Snow, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. J. Eric Evans
Mr. J. Eric Evans
Independent Director
Independent Director
--
--
Mr. Thomas G. Mckinley
Mr. Thomas G. Mckinley
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
156.64K
--
Ms. Mala Murthy
Ms. Mala Murthy
Chief Financial Officer
Chief Financial Officer
132.44K
-9.47%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
69.77K
-7.68%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
50.27K
-8.47%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+117.92%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q3
FY2022Q2
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Access Fees Revenue
525.74M
83.53%
Other
103.63M
16.47%
Nach RegionUSD
Name
Umsatz
Anteil
United States
524.97M
83.41%
International
104.40M
16.59%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Access Fees Revenue
525.74M
83.53%
Other
103.63M
16.47%
Aktionärsstatistik
Aktualisiert: Sat, Aug 16
Aktualisiert: Sat, Aug 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.83%
BlackRock Institutional Trust Company, N.A.
6.91%
Point72 Asset Management, L.P.
4.44%
Renaissance Technologies LLC
4.14%
Dimensional Fund Advisors, L.P.
3.15%
Andere
69.53%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.83%
BlackRock Institutional Trust Company, N.A.
6.91%
Point72 Asset Management, L.P.
4.44%
Renaissance Technologies LLC
4.14%
Dimensional Fund Advisors, L.P.
3.15%
Andere
69.53%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
29.83%
Investment Advisor/Hedge Fund
20.69%
Hedge Fund
17.38%
Research Firm
4.63%
Individual Investor
1.09%
Bank and Trust
0.71%
Pension Fund
0.53%
Sovereign Wealth Fund
0.10%
Insurance Company
0.03%
Andere
25.01%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
998
134.63M
76.20%
-42.03M
2025Q1
1041
132.44M
75.49%
-42.98M
2024Q4
1063
134.61M
77.51%
-37.55M
2024Q3
1133
134.94M
78.45%
-32.89M
2024Q2
1195
142.47M
83.22%
-14.73M
2024Q1
1317
130.90M
77.27%
-19.41M
2023Q4
1432
129.36M
77.56%
-18.52M
2023Q3
1538
125.63M
75.92%
-38.92M
2023Q2
1640
129.13M
78.35%
-41.97M
2023Q1
1761
137.47M
83.88%
-27.34M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
19.64M
11.19%
+1.21M
+6.57%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
12.78M
7.28%
-896.50K
-6.56%
Mar 31, 2025
Point72 Asset Management, L.P.
6.51M
3.71%
-4.67M
-41.77%
Mar 31, 2025
Renaissance Technologies LLC
6.55M
3.73%
+871.70K
+15.36%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
5.05M
2.88%
+1.52M
+43.03%
Mar 31, 2025
Two Sigma Investments, LP
5.30M
3.02%
+1.02M
+23.96%
Mar 31, 2025
State Street Global Advisors (US)
5.01M
2.86%
-66.10K
-1.30%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.07M
2.32%
+118.01K
+2.99%
Mar 31, 2025
Wellington Management Company, LLP
2.59M
1.48%
-545.86K
-17.40%
Mar 31, 2025
Maple Rock Capital Partners, Inc.
3.35M
1.91%
-213.66K
-6.00%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Wed, Aug 6
Aktualisiert: Wed, Aug 6
Name
Anteil
Global X HealthTech ETF
1.29%
Fidelity Digital Health ETF
1.28%
First Trust Indxx Metaverse ETF
0.97%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.63%
Principal U.S. Small-Cap ETF
0.48%
Langar Global HealthTech ETF
0.4%
iShares U.S. Healthcare Providers ETF
0.21%
SPDR S&P Kensho New Economies Composite ETF
0.21%
Royce Quant Small-Cap Quality Value ETF
0.2%
Vanguard US Value Factor ETF
0.17%
Mehr Anzeigen
Global X HealthTech ETF
Anteil1.29%
Fidelity Digital Health ETF
Anteil1.28%
First Trust Indxx Metaverse ETF
Anteil0.97%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil0.63%
Principal U.S. Small-Cap ETF
Anteil0.48%
Langar Global HealthTech ETF
Anteil0.4%
iShares U.S. Healthcare Providers ETF
Anteil0.21%
SPDR S&P Kensho New Economies Composite ETF
Anteil0.21%
Royce Quant Small-Cap Quality Value ETF
Anteil0.2%
Vanguard US Value Factor ETF
Anteil0.17%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
